Tiffany Boone was not always as confident in her acting career as she should be. The actress had given up after a disappointing slew of parts and was getting ready to quit the industry. When Boone started acting again, her first audition was for Lena Waithe’s new series on Showtime, “The Chi.” She tells Cheddar that she had auditioned for a part in the show years ago, but the project was put on hold and she didn't get the role. Years later, she tried again and landed the part of Jerrika on the Showtime drama that premiered Sunday, January 7th. With a grand total of 1.68 million viewers over multiple platforms, the debut of The Chi proved the best premiere for Showtime since Billions opened on January 2016. Boone also opened up about the importance of arts for children and how she personally found solace in the creative outlet growing up with her mom in Baltimore after her father was killed when she was just three years old. "The Chi" currently airs Sunday's on Showtime.

Share:
More In Culture
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
First-Time Homebuyers Face Rising Mortgage Rates
Buying a new home is tough right now; but for first-time buyers, it's an especially challenging time, with obstacles like rising mortgage rates and record-breaking home prices. The housing market is not expected to get much friendlier, as mortgage rates are expected to continue to climb as the Federal Reserve proceeds with its plans for rate hikes in an effort to stifle inflation. Jonathan Miller, President and CEO of real estate appraiser Miller Samuel, joins Cheddar News' Closing Bell to discuss.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Load More